BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND HOXA11, HOX1, 3207, ENSG00000005073, HOX1I, P31270
7 results:

  • 1. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
    Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
    Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Downregulation of hoxa11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway.
    Kong C; Zhu Z; Li Y; Xue P; Chen L
    Clin Transl Oncol; 2021 Jul; 23(7):1334-1341. PubMed ID: 33515421
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
    Vora A; Goulden N; Wade R; Mitchell C; Hancock J; Hough R; Rowntree C; Richards S
    Lancet Oncol; 2013 Mar; 14(3):199-209. PubMed ID: 23395119
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma.
    Bennett LB; Schnabel JL; Kelchen JM; Taylor KH; Guo J; Arthur GL; Papageorgio CN; Shi H; Caldwell CW
    Genes Chromosomes Cancer; 2009 Sep; 48(9):828-41. PubMed ID: 19530241
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. In vivo drug-response in patients with leukemic non-Hodgkin's lymphomas is associated with in vitro chemosensitivity and gene expression profiling.
    Chow KU; Nowak D; Kim SZ; Schneider B; Komor M; Boehrer S; Mitrou PS; Hoelzer D; Weidmann E; Hofmann WK
    Pharmacol Res; 2006 Jan; 53(1):49-61. PubMed ID: 16213748
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and hoxa11 in a subset of T-cell acute lymphoblastic leukemias.
    Speleman F; Cauwelier B; Dastugue N; Cools J; Verhasselt B; Poppe B; Van Roy N; Vandesompele J; Graux C; Uyttebroeck A; Boogaerts M; De Moerloose B; Benoit Y; Selleslag D; Billiet J; Robert A; Huguet F; Vandenberghe P; De Paepe A; Marynen P; Hagemeijer A
    Leukemia; 2005 Mar; 19(3):358-66. PubMed ID: 15674412
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Expression of selected human HOX-2 genes in B/T acute lymphoid leukemia and interleukin-2/interleukin-1 beta-stimulated natural killer lymphocytes.
    Petrini M; Quaranta MT; Testa U; Samoggia P; Tritarelli E; Carè A; Cianetti L; Valtieri M; Barletta C; Peschle C
    Blood; 1992 Jul; 80(1):185-93. PubMed ID: 1351762
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.